NCT02792140View on ClinicalTrials.gov

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Neuroscience of Dreaming, Healthy
Interventions
DRUG

Naltrexone

one week

OTHER

Placebo

one week

Trial Locations (1)

3012

University of Bern, Bern

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

University of Bern

OTHER

NCT02792140 - The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams | Biotech Hunter | Biotech Hunter